Mirtazapine-d3

Mirtazapine-d3 is a deuterium labeled Mirtazapine. Mirtazapine is a 5-HT receptor inhibitor. Mirtazapine is a potent and orally active noradrenergic and specific serotonergic antidepressant (NaSSA) agent by blocking 5-HT2 and 5-HT3 receptors[1].

Product Specifications

CAS Number

[1216678-68-0]

Product Name Alternative

Org3770 D3; 6-Azamianserin D3

UNSPSC

12352005

Hazard Statement

H302-H336-H411

Target

5-HT Receptor

Type

Isotope-Labeled Compounds

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Purity

98.55

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

[2H]C([2H])([2H])N1CC2C3=CC=CC=C3CC4=CC=CN=C4N2CC1

Molecular Formula

C17H16D3N3

Molecular Weight

268.38

Precautions

P261-P264-P273-P391-P501

References & Citations

[1]Anttila, S.A. and E.V. Leinonen, A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev, 2001. 7 (3) : p. 249-64.|[2]Kooyman AR, et al. Interaction between enantiomers of mianserin and ORG3770 at 5-HT3 receptors in cultured mouse neuroblastoma cells.Neuropharmacology. 1994 Mar-Apr;33 (3-4) :501-7.